Precigen Inc (PGEN)
1.29
-0.04
(-3.01%)
USD |
NASDAQ |
May 09, 16:00
1.29
0.00 (0.00%)
After-Hours: 20:00
Precigen Shareholders Equity (Quarterly): 118.50M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 118.50M |
| September 30, 2023 | 147.68M |
| June 30, 2023 | 166.21M |
| March 31, 2023 | 184.13M |
| December 31, 2022 | 126.26M |
| September 30, 2022 | 142.53M |
| June 30, 2022 | 55.65M |
| March 31, 2022 | 73.84M |
| December 31, 2021 | 107.35M |
| September 30, 2021 | 131.25M |
| June 30, 2021 | 159.20M |
| March 31, 2021 | 174.80M |
| December 31, 2020 | 67.17M |
| September 30, 2020 | 58.55M |
| June 30, 2020 | 49.54M |
| March 31, 2020 | 87.23M |
| December 31, 2019 | 71.71M |
| September 30, 2019 | 228.42M |
| June 30, 2019 | 279.22M |
| March 31, 2019 | 313.03M |
| December 31, 2018 | 362.86M |
| September 30, 2018 | 539.40M |
| June 30, 2018 | 549.75M |
| Date | Value |
|---|---|
| March 31, 2018 | 553.11M |
| December 31, 2017 | 533.63M |
| September 30, 2017 | 533.61M |
| June 30, 2017 | 550.87M |
| March 31, 2017 | 528.54M |
| December 31, 2016 | 560.24M |
| September 30, 2016 | 600.47M |
| June 30, 2016 | 619.23M |
| March 31, 2016 | 664.93M |
| December 31, 2015 | 694.08M |
| September 30, 2015 | 718.29M |
| June 30, 2015 | 474.84M |
| March 31, 2015 | 640.67M |
| December 31, 2014 | 384.76M |
| September 30, 2014 | 358.36M |
| June 30, 2014 | 373.26M |
| March 31, 2014 | 415.90M |
| December 31, 2013 | 366.72M |
| September 30, 2013 | 377.13M |
| June 30, 2013 | -376.15M |
| March 31, 2013 | 112.67M |
| December 31, 2012 | -321.55M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
49.54M
Minimum
Jun 2020
279.22M
Maximum
Jun 2019
127.85M
Average
126.26M
Median
Dec 2022
Shareholders Equity (Quarterly) Benchmarks
| Cyclacel Pharmaceuticals Inc | 0.607M |
| HealthEquity Inc | 2.035B |
| Corvus Pharmaceuticals Inc | 38.68M |
| Oragenics Inc | 3.168M |
| MAIA Biotechnology Inc | 0.4775M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 151.04M |
| Total Liabilities (Quarterly) | 32.54M |
| Current Ratio | 2.991 |
| Net Debt Paydown Yield | 4.92% |